Clinical Trial

Whole-life Investigation of Lishui Longevity

Study acronym: WILL
Recruiting
View on ClinicalTrials.gov →
Summary
1. To establish a standardized, normalized and scientific joint screening and follow-up management system for chronic disease multimorbidity in Lishui City, and early identify common risk factors of major chronic diseases such as cardiovascular and cerebrovascular diseases and tumors. 2. To carry out targeted intervention and long-term follow-up for high-risk populations, reduce the incidence risk of major chronic diseases in the target population, improve residents' health status and grassroots comprehensive prevention and treatment capacity of chronic diseases, and provide scientific evidence and practical support for the construction of Healthy Lishui.
Trial Details
NCT Number NCT07592962
Lead Sponsor The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital
Conditions Ischemic Stroke, Chronic Disease, Cardiovascular
Enrollment 4,500 participants
Start Date 2026-05-18
Primary Completion 2036-05-31 (estimated)
Study Completion 2036-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18